Vismodegib is a Hedgehog pathway inhibitor indicated for the treatment of metastatic or locally advanced basal cell carcinoma. By acting as a selective antagonist of the Smoothened receptor, this medication… Read more
































Vismodegib is a Hedgehog pathway inhibitor indicated for the treatment of metastatic or locally advanced basal cell carcinoma. By acting as a selective antagonist of the Smoothened receptor, this medication blocks the activation of GLI transcription factors to inhibit tumor progression. This category offers a comprehensive range of Vismodegib reference standards, metabolites, and synthetic intermediates essential for pharmaceutical quality control and analytical method validation. These materials facilitate precise impurity profiling, allowing for the identification and quantification of process-related impurities and degradation products formed through pathways such as hydrolysis or oxidation. Furthermore, the inclusion of stable isotope labelled compounds provides investigators with reliable internal standards necessary for accurate analyte detection in complex matrices. These characterized reference compounds support adherence to pharmacopeial specifications and help ensure stringent quality assessment throughout drug development and manufacturing processes.